RoLEP™ (Robotic-assisted HoLEP)
Benign Prostatic Hyperplasia (BPH)
UnknownActive
Key Facts
About Andromeda Surgical
Andromeda Surgical is a private, pre-revenue company pioneering an open, AI-driven surgical robotics platform. Founded in 2023 by entrepreneurs with deep expertise in medtech and autonomous systems, the company has already achieved a clinical milestone with the world's first robotic-assisted HoLEP procedure. By forging strategic partnerships with established medical device companies and leveraging a continuous software-update model, Andromeda aims to scale from urology into a multi-specialty platform that democratizes expert-level surgical care.
View full company profileTherapeutic Areas
Other Benign Prostatic Hyperplasia (BPH) Drugs
| Drug | Company | Phase |
|---|---|---|
| Prolieve Thermodilatation System | Medifocus | Marketed |
| Optilume BPH Catheter System | Laborie | Commercial |
| Zenflow Procedure | Zenflow | Clinical Evaluation |
| TULSA-PRO® | Profound Medical | Commercial |
| Fexapotide Triflutate (NX-1207) | Nymox Pharmaceutical | Phase 3 |